| Property | Value | [1]
|----------|-------| [2]
| Category | Limbic System, Basal Forebrain | [3]
| Location | Medial septum, vertical limb of diagonal band | [4]
| Cell Type | Cholinergic projection neurons (Ch1-Ch2) | [5]
| Neurotransmitters | Acetylcholine, GABA, glutamate |
| Primary Function | Hippocampal theta rhythm, memory consolidation |
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000108 | cholinergic neuron |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000108 | cholinergic neuron | Medium |
| Cell Ontology | CL:0000787 | memory B cell | Medium |
| Cell Ontology | CL:0000813 | memory T cell | Medium |
Medial septal (MS) cholinergic neurons form the major cholinergic input to the hippocampal formation, playing a critical role in memory formation, spatial navigation, and hippocampal theta oscillations. These neurons are among the first to degenerate in Alzheimer's disease, making them central to understanding memory impairment in neurodegenerative conditions.
MS cholinergic neurons express a characteristic set of molecular markers:
Cholinergic Markers:
Receptor Expression:
Transcription Factors:
MS cholinergic neurons receive input from:
MS neurons project to:
MS cholinergic neurons are pacemakers for hippocampal theta oscillations (4-12 Hz), essential for:
Cholinergic signaling in hippocampus:
MS cholinergic system:
MS cholinergic neurons are severely affected in AD:
Mechanisms:
Cholinergic Enhancement:
The study of Medial Septal Cholinergic In Memory Disorders has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Geula C et al. Cholinergic neurons in the basal forebrain in AD. Neurology. 1995. 1995. ↩︎
Sassin I et al. Tau pathology in the septal region. Acta Neuropathol. 2000. 2000. ↩︎
Hampel H et al. Cholinergic therapy for Alzheimer's disease. Nat Rev Drug Discov. 2019. 2019. ↩︎
Bohnen NI et al. Cholinergic dysfunction in Parkinson's disease. Ann Neurol. 2019. 2019. ↩︎
Shiozaki K et al. Cholinergic deficiency in DLB. J Neurol Neurosurg Psychiatry. 1999. 1999. ↩︎